GlassScriptPhysician profile
Afsaneh Amini
NPI 1790099943
$4,933.66
in general payments reported to CMS, 2019-2025
18 companies · $470 in 2025
The $470 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $511 · 2021: $1,141 · 2022: $973 · 2023: $438 · 2024: $360 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,727.50 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $962.36 | 2022-2024 | Infuse, Miebo, Vyzulta |
| Coopervision INC. | $453.56 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Alcon Vision LLC | $377.90 | 2019-2025 | Tryptyr |
| Amgen INC. | $266.72 | 2025 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $263.84 | 2019-2025 | Acuvue |
| Abbvie INC. | $213.86 | 2022-2025 | |
| Glaukos Corporation | $144.40 | 2021 | |
| Shire North American Group INC | $120.43 | 2019 | |
| Allergan, INC. | $116.22 | 2022 | |
| Thea Pharma INC. | $99.35 | 2022-2024 | Iyuzeh |
| Sight Sciences, INC. | $62.60 | 2020 | |
| Novartis Pharmaceuticals Corporation | $30.72 | 2022-2023 | |
| Beaver-Visitec International, INC. | $23.03 | 2022 | |
| Horizon Therapeutics Plc | $20.49 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $18.57 | 2024 | Ryzumvi, Tyrvaya |
| Lombart Brothers, INC. | $12.71 | 2025 | Opd-III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afsaneh Amini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.